文献速递性腺与生殖内分泌

青少年期抗苗勒管激素与成年多囊卵巢综合征长期随访关系

Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

结果显示青少年AMH在成年PCOS者中较高,但单独或联合青少年月经稀发均不能作为成年PCOS的预后标志,不建议临床常规使用。

要点

  • 青少年月经稀发者AMH中位数4.6 μg/L,高于规律周期者2.6 μg/L。
  • 成年PCOS者青少年期AMH中位数6.0 μg/L,非PCOS组为2.5 μg/L。
  • 青少年AMH预测成年PCOS的ROC曲线下面积为0.78,但联合月经稀发无增益。

核心结论

  • 青少年AMH单独使用或作为青少年月经稀发的辅助因素,均不能作为成年PCOS的预后标志,因此不建议临床常规使用。

主要发现

  • 青少年月经稀发者AMH中位数为4.6(3.1-7.5)μg/L,规律周期者为2.6(1.7-3.8)μg/L(P < 0.001)。
  • 成年PCOS者青少年期AMH中位数为6.0 μg/L,非PCOS组为2.5 μg/L(P < 0.001)。
  • 青少年AMH预测成年PCOS的ROC曲线下面积为0.78。
  • 青少年月经稀发者成年PCOS比例为22.5%(95% CI,12.4-37.4),规律周期者为5.1%(95% CI,2.1-12.0)(P = 0.005)。
  • 在青少年月经稀发背景下,加入高AMH对预测成年PCOS或成年月经稀发无价值。

临床怎么用

  • 不建议将青少年期AMH常规用于临床预测成年PCOS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Anti-Müllerian hormone (AMH) measured in adolescence as biomarker for prediction of adult polycystic ovary syndrome (PCOS) is doubtful but not substantiated. OBJECTIVE: To investigate whether serum AMH levels and other PCOS-associated features in adolescence can predict the presence of PCOS in adulthood. DESIGN AND SETTING: A long-term follow-up study based on a unique adolescent study on menstrual irregularities performed between 1990 and 1997. PARTICIPANTS AND INTERVENTIONS: AMH was assayed in 271 adolescent girls. Data on PCOS features were combined with AMH levels. In 160 of the 271 (59%) participants, we collected information in adulthood about their menstrual cycle pattern and presence of PCOS (features) by questionnaire 2 decades after the initial study. RESULTS: AMH was higher in adolescent girls with oligomenorrhea compared with girls with regular cycles, median (interquartile range): 4.6 (3.1-7.5) versus 2.6 (1.7-3.8) μg/L (P < 0.001). Women with PCOS in adulthood had a higher median adolescent AMH of 6.0 compared with 2.5 μg/L in the non-PCOS group (P < 0.001). AMH at adolescence showed an area under the receiver operating characteristic curve for PCOS in adulthood of 0.78. In adolescent girls with oligomenorrhea the proportion developing PCOS in adulthood was 22.5% (95% CI, 12.4-37.4) against 5.1% (95% CI, 2.1-12.0) in girls with a regular cycle (P = 0.005). Given adolescent oligomenorrhea, adding high AMH as factor to predict adult PCOS or adult oligomenorrhea was of no value. CONCLUSIONS: Adolescent AMH either alone or adjuvant to adolescent oligomenorrhea does not contribute as prognostic marker for PCOS in adulthood. Therefore, we do not recommend routine its use in clinical practice.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Caanen MR, Peters HE, van de Ven PM, et al. Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2021. PMID: 33351079. doi:10.1210/clinem/dgaa949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。